Skip to content
Search

Latest Stories

STADA appoints Wolfgang Ollig as Group CFO

STADA, parent company of Yorkshire based pharmaceutical company Thornton & Ross, named Wolfgang Ollig as its new Group Chief Financial Officer.

Ollig replaces Mark Keatley who decided to step down for personal reasons. He will take up the new role on February 1.


Ollig has more than 15 years of experience in the role at various industries including medical and automotive. He has recently worked for hearing aid manufacturers WSA, A.S. Denmark, based in Singapore. Prior to this, he served Hella KGaA Hueck & Co ten years as Group CFO.

He also worked several years at McKinsey.

“Wolfgang’s deep knowledge in managing all financial aspects of a global company with broad portfolios, as well as his passion and strong credibility, will help to accelerate STADA’s ongoing growth journey,” said Peter Goldschmidt, STADA Chief Executive.

Ollig is expected to play a crucial part in realising the company's vision of becoming the partner of choice in generics as well as in consumer health and to outperform the industry in terms of growth and profitability.

“I am really looking forward to joining the team and contributing to making STADA the leading company in the industry,” he said.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less